Impact of fluconazole disk diffusion susceptibility testing on management of Candidemia
S. Tantasuwan, P. Chongtrakool, M. Chayakulkeeree
International Journal of Infectious Diseases · 2020
doi:10.1016/j.ijid.2020.09.1013 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Background: Antifungal de-escalation in candidemia patients when clinically appropriate could decrease treatment-related toxicity and antifungal costs without affecting clinical outcomes. Disk diffusion (DD) antifungal susceptibility testing is a simple and accurate method for fluconazole susceptibility of Candida.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.